Second-line chemotherapy for non-small cell lung cancer

被引：0
|
作者：
Ruckdeschel, JC
机构：
[1] Univ Washington, Pulm Crit Care Med Div, Seattle, WA 98195 USA
[2] Swedish Med Ctr, Englewood, CO 80110 USA
[3] Univ Washington, Cardiothorac & Trauma Surg Div, Seattle, WA 98195 USA
来源：
CHEST | 2006年 / 129卷 / 04期
关键词：
D O I：
10.1378/chest.129.4.840
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：840 / 842
页数：3
相关论文
共 50 条
  • [41] Second-line treatment for advanced non-small cell lung cancer:: A systematic review
    Barlési, F
    Jacot, W
    Astoul, P
    Pujol, JL
    [J]. LUNG CANCER, 2006, 51 (02) : 159 - 172
  • [42] Docetaxel and mitomycin as second-line treatment in advanced non-small cell lung cancer
    Feliu, J.
    Martin, G.
    Castro, J.
    Sundlov, A.
    Rodriguez-Jaraiz, A.
    Casado, E.
    Lomas, M.
    Madronal, C.
    Galan, A.
    Belda, C.
    Gonzalez-Baron, M.
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 58 (04) : 527 - 531
  • [43] Evaluation of second-line treatment options in non-small cell lung cancer - Introduction
    Scagliotti, GV
    [J]. SEMINARS IN ONCOLOGY, 2006, 33 (01) : S1 - S2
  • [44] Antiangiogenic agents as second-line therapy for advanced non-small cell lung cancer
    Reckamp, Karen L.
    [J]. CANCER LETTERS, 2012, 321 (02) : 101 - 109
  • [45] Cisplatin combination regimen in the second-line treatment of non-small cell lung cancer
    Altundag, O.
    Mertsoylu, H.
    Akcall, Z.
    Sakalli, H.
    Ozyilkan, O.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [46] Efficacy of vinorelbine in the second-line setting and beyond in non-small cell lung cancer
    Subramanian, Janakiraman
    Velcheti, Vamsidhar
    Baggstrom, Maria Q.
    Govindan, Ramaswamy
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (04) : 373 - 373
  • [47] Influence of first-line chemotherapy and EGFR mutations on second-line gefitinib in advanced non-small cell lung cancer
    Wu, Jenn-Yu
    Yu, Chong-Jen
    Shih, Jin-Yuan
    Yang, Chih-Hsin
    Yang, Pan-Chyr
    [J]. LUNG CANCER, 2010, 67 (03) : 348 - 354
  • [48] Second-line chemotherapy for small-Cell Lung Cancer (SCLC)
    Kim, Young Hak
    Mishima, Michiaki
    [J]. CANCER TREATMENT REVIEWS, 2011, 37 (02) : 143 - 150
  • [49] Second-line chemotherapy and its evaluation in small cell lung cancer
    Huisman, C
    Postmus, PE
    Giaccone, G
    Smit, EF
    [J]. CANCER TREATMENT REVIEWS, 1999, 25 (04) : 199 - 206
  • [50] Efficacy and safety of second-line chemotherapy for patients with advanced non-small cell lung cancer complicated by interstitial lung disease
    Otsuka, Kenji
    Nokihara, Hiroshi
    Mitsuhashi, Atsushi
    Ozaki, Ryohiko
    Yabuki, Yohei
    Yoneda, Hiroto
    Ogino, Hirokazu
    Nishioka, Yasuhiko
    [J]. THORACIC CANCER, 2022, 13 (21) : 2978 - 2984
12345